NHS Set to Adopt Fast, Non-Invasive Oesophageal Cancer Test

health

Yesterday, the NHS is preparing to roll out a revolutionary seven-minute sponge-on-a-string test that could catch oesophageal cancer early, according to a new Nice recommendation.

Nice has recommended two rapid screening tools - Cytosponge and EndoSign - for nationwide deployment, after pilots showed the non-sedative technology can be used in GP surgeries, local pharmacies and community diagnostic centres. The patient swallows a capsule that releases a sponge, which is pulled back after about seven minutes to collect cells from the oesophageal lining for laboratory analysis.

The quick, less invasive test is favoured over traditional endoscopy and could help identify the more than 9,000 people diagnosed with oesophageal cancer each year in the UK earlier, when treatment is more effective. It also offers monitoring for the 1-2 % of adults with Barrett's oesophagus, a condition linked to chronic acid reflux.

The recommendation marks Nice's first under the National HealthTech Access Programme, aiming to accelerate adoption of high-impact technologies across the NHS, with pilots already benefitting thousands of patients.